Pain being trained on Riva!!!

Quote








J&J loves specialty sales forces and most of the new products fit in that area. AI/GI has contract sales reps. Could be that primary care is going to contract sales reps!
 












There will be no training on anything until the end of respiratory season. Then and only then the new training will begin. However, it will be with a new company once you find employment.

Riva is again delayed folks, wake up.
 








Anonymous; said:
Pain is being trained on Riva! Seeding the orthopedic market. What does that saw about AI/GI?
Click to expand...

Does not mean shit? If you listened you know they call on OS so they are being trained now AIGI for later indications. Just do your job and AIGI was a primary contributor to Nucynta's success.
 




















Anonymous said:
Year end at best. Maybe 2012. Ask your RBD, nah, scratch that last one, they're all on LinkedIn updating their contacts for near-future reference.
Click to expand...

I looked on line to see if I could find any notifications from the FDA about a delay and couldn't find anything. Has anyone been officially notified from any source? I really wanted to sell this one. Just curious also if you know the reason sited for the delay.
 




















Anonymous said:
I know, as if this would be shocking news...Hey, instead of hiring hundreds only to lay them off later why not train a sales force that already works for J&J !!! Genius!!! cant belive someone thought to do this....amazing

Boy... someone's earned an encore award
Click to expand...

You will be retrained on Xarelto a couple more times before the green light, seen it, done it with other J&J products.
 




Home Office

It is just a matter of time. The decision have been made. It came down to profits. Profits are winding down from Leva, and Aci how small they are but the profits are starting for Nucynta. there is one problem with Nucynta that is ER there is yet another delay. The IR is not brining in profits yet and they will not keep 1750 people selling it forever.

Bottom line without any AI/GI medication there is not AI/GI sales team. There will be no Pain specialty division and all this will be finalized and rolled out with in the next 30 days! There will be a combination and they will be selling Rivo,Nucy,ACI,Remi and they will be called Retail sales team. The bad news is there will not be 940 which is the rough count now, they have not finalized the numbers yet they are still waiting to see exact dates on Rivo's FM indication and NucER time line.
 




Anonymous said:
Home Office

It is just a matter of time. The decision have been made. It came down to profits. Profits are winding down from Leva, and Aci how small they are but the profits are starting for Nucynta. there is one problem with Nucynta that is ER there is yet another delay. The IR is not brining in profits yet and they will not keep 1750 people selling it forever.

Bottom line without any AI/GI medication there is not AI/GI sales team. There will be no Pain specialty division and all this will be finalized and rolled out with in the next 30 days! There will be a combination and they will be selling Rivo,Nucy,ACI,Remi and they will be called Retail sales team. The bad news is there will not be 940 which is the rough count now, they have not finalized the numbers yet they are still waiting to see exact dates on Rivo's FM indication and NucER time line.
Click to expand...

That all makes perfect sense except the 30 day timeline. End of the quarter (June) would make more sense. Perhaps you mean the changes will be rolled out to upper management, then mid-management, then the field. Your post suggests a possible head-count reduction or does it suggest an expansion??? Do you know if pods are back on the table? Thanks for what seems like an accurate or at least honest post.
 




Top Bottom
Back
Quote